First human tests: scientists check safety of new capsule
NCT ID NCT06279533
Summary
This early-stage study aimed to understand the safety and how the body processes a new capsule called LV232. It involved 49 healthy volunteers to test different doses and see if eating food changes how the capsule is absorbed. The main goal was to gather basic safety and absorption data to see if future studies in patients are warranted.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY SUBJECTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shanghai Xuhui Central Hospital
Shanghai, China
Conditions
Explore the condition pages connected to this study.